Detalhe da pesquisa
1.
HSC Niche Dynamics in Regeneration, Pre-malignancy, and Cancer: Insights From Mathematical Modeling.
Stem Cells
; 41(3): 260-270, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371719
2.
Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms.
Br J Haematol
; 202(2): 318-327, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211985
3.
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up.
Eur J Haematol
; 109(5): 576-585, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054308
4.
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
N Engl J Med
; 379(15): 1416-1430, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304655
5.
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population.
Blood
; 134(5): 469-479, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217187
6.
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
BMC Cancer
; 21(1): 691, 2021 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112113
7.
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Eur J Haematol
; 107(6): 624-633, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411333
8.
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people.
Br J Haematol
; 189(2): 323-334, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875952
9.
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives.
J Neuroinflammation
; 17(1): 248, 2020 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829706
10.
The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera.
Eur J Haematol
; 104(1): 46-54, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584701
11.
Bridging blood cancers and inflammation: The reduced Cancitis model.
J Theor Biol
; 465: 90-108, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615883
12.
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment.
Eur J Haematol
; 103(4): 351-361, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297883
13.
Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia.
Eur J Haematol
; 100(1): 45-52, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960473
14.
Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms.
Eur J Haematol
; 100(6): 550-559, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464777
15.
Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).
Platelets
; 28(5): 478-483, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819522
16.
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.
Eur J Haematol
; 97(1): 83-92, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385526
17.
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
Eur J Haematol
; 94(3): 227-34, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082025
18.
Association of the blood eosinophil count with hematological malignancies and mortality.
Am J Hematol
; 90(3): 225-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488524
19.
Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes.
J Immunol
; 191(8): 4059-67, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24048901
20.
Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.
Eur J Haematol
; 93(3): 224-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24689875